redlight.store

🐁 Mouse · 2019 · Russia (Saratov)

Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease

Zinchenko · Biomed Opt Express · 2019

The protocol this study used

Wavelength
1267 nm
Dose
32 J/cm²
Sessions
5
Per session
—

What the authors concluded

The results of this pilot study clearly demonstrate that 9 days course of tPBM (1267 nm, 32 J/cm2 ) reduces Aβplaques in the brain of mice with AD and improved the memory and neurocognitive deficit. The tPBM-mediated stimulation of lymphatic drainage might be one of mechanism underlying tPBM elimination of Aβ from the brain.

Source

PubMed 31452991 →

Dosimetry extracted by Vladimir Heiskanen in Photobiomodulation (PBM) research - a comprehensive database. Citation resolved against PubMed.